These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
370 related articles for article (PubMed ID: 29189185)
21. Development and in vitro evaluation of pressure sensitive adhesive patch for the transdermal delivery of galantamine: Effect of penetration enhancers and crystallization inhibition. Ameen D; Michniak-Kohn B Eur J Pharm Biopharm; 2019 Jun; 139():262-271. PubMed ID: 30981946 [TBL] [Abstract][Full Text] [Related]
22. Drug in adhesive transdermal patch containing antibiotic-loaded solid lipid nanoparticles. Nasrollahzadeh M; Ganji F; Taghizadeh SM; Vasheghani-Farahani E; Mohiti-Asli M J Biosci Bioeng; 2022 Nov; 134(5):471-476. PubMed ID: 36151004 [TBL] [Abstract][Full Text] [Related]
23. Enhanced transdermal delivery of an anti-hypertensive agent via nanoethosomes: statistical optimization, characterization and pharmacokinetic assessment. Ahad A; Aqil M; Kohli K; Sultana Y; Mujeeb M Int J Pharm; 2013 Feb; 443(1-2):26-38. PubMed ID: 23313344 [TBL] [Abstract][Full Text] [Related]
24. Development of alginate-reinforced chitosan nanoparticles utilizing W/O nanoemulsification/internal crosslinking technique for transdermal delivery of rabeprazole. Ahmed TA; El-Say KM Life Sci; 2014 Aug; 110(1):35-43. PubMed ID: 24997393 [TBL] [Abstract][Full Text] [Related]
25. Optimization and charaterization of repaglinide biodegradable polymeric nanoparticle loaded transdermal patchs: in vitro and in vivo studies. Vijayan V; Reddy KR; Sakthivel S; Swetha C Colloids Surf B Biointerfaces; 2013 Nov; 111():150-5. PubMed ID: 23792547 [TBL] [Abstract][Full Text] [Related]
26. Design and evaluation of patches for transdermal delivery of losartan potassium. Baviskar DT; Parik VB; Gupta HN; Maniyar AH; Jain DK PDA J Pharm Sci Technol; 2012; 66(2):126-35. PubMed ID: 22492598 [TBL] [Abstract][Full Text] [Related]
27. Development of transmucosal patch loaded with anesthetic and analgesic for dental procedures and in vivo evaluation. Nidhi M; Patro MN; Kusumvalli S; Kusumdevi V Int J Nanomedicine; 2016; 11():2901-20. PubMed ID: 27382279 [TBL] [Abstract][Full Text] [Related]
28. Formulation and assessment of hydroxyzine HCL solid lipid nanoparticles by dual emulsification technique for transdermal delivery. El-Telbany DFA; El-Telbany RFA; Zakaria S; Ahmed KA; El-Feky YA Biomed Pharmacother; 2021 Nov; 143():112130. PubMed ID: 34560549 [TBL] [Abstract][Full Text] [Related]
29. Tailoring novel soft nano-vesicles 'Flexosomes' for enhanced transdermal drug delivery: Optimization, characterization and comprehensive ex vivo - in vivo evaluation. Abdel-Messih HA; Ishak RAH; Geneidi AS; Mansour S Int J Pharm; 2019 Apr; 560():101-115. PubMed ID: 30753931 [TBL] [Abstract][Full Text] [Related]
30. Formulation and Optimization of Solid Lipid Nanoparticle-based Gel for Dermal Delivery of Linezolid using Taguchi Design. Chauhan I; Singh L Recent Adv Antiinfect Drug Discov; 2024; 19(4):322-347. PubMed ID: 38243985 [TBL] [Abstract][Full Text] [Related]
31. Nanostructured Lipid Carrier-Mediated Transdermal Delivery System of Glibenclamide for Gestational Diabetes: Pharmacokinetic and Pharmacodynamic Evaluation. Ashwini M; Sudheer P; Sogali BS Curr Drug Deliv; 2024; 21(10):1386-1407. PubMed ID: 38213159 [TBL] [Abstract][Full Text] [Related]
32. Formulation design and development of matrix diffusion controlled transdermal drug delivery of glimepiride. Akram MR; Ahmad M; Abrar A; Sarfraz RM; Mahmood A Drug Des Devel Ther; 2018; 12():349-364. PubMed ID: 29503528 [TBL] [Abstract][Full Text] [Related]
33. Fabrication and characterization of matrix type transdermal patches loaded with tizanidine hydrochloride: potential sustained release delivery system. Shahid N; Siddique MI; Razzaq Z; Katas H; Waqas MK; Rahman KU Drug Dev Ind Pharm; 2018 Dec; 44(12):2061-2070. PubMed ID: 30081679 [TBL] [Abstract][Full Text] [Related]
34. The Effect and Mechanism of Transdermal Penetration Enhancement of Fu's Cupping Therapy: New Physical Penetration Technology for Transdermal Administration with Traditional Chinese Medicine (TCM) Characteristics. Xie WJ; Zhang YP; Xu J; Sun XB; Yang FF Molecules; 2017 Mar; 22(4):. PubMed ID: 28346390 [TBL] [Abstract][Full Text] [Related]
35. Furosemide - Soluplus® Solid Dispersion: Development and Characterization. Prasad R; Radhakrishnan P; Singh SK; Verma PRP Recent Pat Drug Deliv Formul; 2017; 11(3):211-220. PubMed ID: 29189186 [TBL] [Abstract][Full Text] [Related]
36. An efficient approach for development and optimisation of curcumin-loaded solid lipid nanoparticles' patch for transdermal delivery. Sabir F; Qindeel M; Rehman AU; Ahmad NM; Khan GM; Csoka I; Ahmed N J Microencapsul; 2021 Jun; 38(4):233-248. PubMed ID: 33689550 [TBL] [Abstract][Full Text] [Related]
37. Repaglinide-Solid Lipid Nanoparticles in Chitosan Patches for Transdermal Application: Box-Behnken Design, Characterization, and In Vivo Evaluation. Ali HSM; Namazi N; Elbadawy HM; El-Sayed AAA; Ahmed SA; Bafail R; Almikhlafi MA; Alahmadi YM Int J Nanomedicine; 2024; 19():209-230. PubMed ID: 38223883 [TBL] [Abstract][Full Text] [Related]
38. Enhancement of the bioavailability of an antihypertensive drug by transdermal protransfersomal system: formulation and in vivo study. Morsi NM; Aboelwafa AA; Dawoud MHS J Liposome Res; 2018 Jun; 28(2):137-148. PubMed ID: 28264602 [TBL] [Abstract][Full Text] [Related]
39. Topical Amphotericin B solid lipid nanoparticles: Design and development. Butani D; Yewale C; Misra A Colloids Surf B Biointerfaces; 2016 Mar; 139():17-24. PubMed ID: 26700229 [TBL] [Abstract][Full Text] [Related]
40. Natural oils as skin permeation enhancers for transdermal delivery of olanzapine: in vitro and in vivo evaluation. Aggarwal G; Dhawan S; HariKumar SL Curr Drug Deliv; 2012 Mar; 9(2):172-81. PubMed ID: 22023211 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]